Cart
sales@molnova.com
Milrinone
CAS No. 78415-72-2
Milrinone ( WIN 47,203 )
Catalog No. M15957 CAS No. 78415-72-2
Milrinone(Win 47203) is a PDE3 inhibitor that increases intracellular cyclic adenosine monophosphate resulting in improved ventricular function and vasodilation.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 32 | In Stock |
|
| 50MG | 47 | In Stock |
|
| 100MG | 73 | In Stock |
|
| 200MG | 97 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMilrinone
-
NoteResearch use only, not for human use.
-
Brief DescriptionMilrinone(Win 47203) is a PDE3 inhibitor that increases intracellular cyclic adenosine monophosphate resulting in improved ventricular function and vasodilation.
-
DescriptionMilrinone(Win 47203) is a PDE3 inhibitor that increases intracellular cyclic adenosine monophosphate resulting in improved ventricular function and vasodilation.
-
SynonymsWIN 47,203
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE2; PDE3
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number78415-72-2
-
Formula Weight211.22
-
Molecular FormulaC12H9N3O
-
Purity>98%(HPLC)
-
SolubilityDMSO: 42 mg/mL (198.84 mM)
-
SMILESN#CC1=CC(C2=CC=NC=C2)=C(C)NC1=O
-
Chemical Name6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cone J, et al. J Cardiovasc Pharmacol, 1999, 34(4), 497-504.
molnova catalog
related products
-
ITI214 free base
ITI-214 is a potent, selective phosphodiesterase 1 (PDE1) inhibitor with Ki of 58 pM.
-
FCPR03
FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively.
-
Cilostazol
Cilostazol (OPC 13013, OPC 21) is a potent inhibitor of PDE3A with IC50 of 0.2 uM; inhibits platelet aggregation and has considerable antithrombotic effects in vivo.
